Biorasi pushes into Western Europe with ABR acquisition

By Zachary Brennan contact

- Last updated on GMT

Biorasi pushes into Western Europe with ABR acquisition

Related tags: Europe

CRO Biorasi has acquired fellow CRO Advanced Biosciences Research (ABR) to expand its operations in the UK, Germany, Switzerland, and Sweden. 

The purchase will add key geographies and services to Biorasi’s offerings as ABR provides Phase II to IV clinical research project management, monitoring, and regulatory outsourcing for its sponsors in the region.

Boris Reznik, Chairman of Biorasi, told Outsourcing-Pharma.com: “Biorasi has been fortunate not to need to acquire backlog, we have been growing fast while relying on our internal bookings capabilities. We have done a couple of acquisitions for the purposes of enhancing our resources in specific areas of the world. ABR acquisition is specifically focused on enhancing our presence in Western Europe​.”
Tigran Arzumanov, ABR Principle, added that his company has been working with Biorasi “for over a year and have been extremely impressed with the superiority of Biorasi's innovative clinical research project delivery model​.” 
Biorasi has been running world-wide clinical trials for over a decade, with a presence in North and South America, Eastern Europe and Asia. Biorasi also has strength in Russia and Ukraine, and a decade-long established presence in Czech Republic, Poland, Serbia, Latvia, and United Kingdom.

The addition of ABR's regional base will create a strong footprint throughout Europe, Reznick said.

The ARB acquisition also follows Biorasi’s acquisition of Ukrainian CRO Sponsors Clinical Research​ Group, which followed a long-standing collaboration between the two companies.

Most of the trials we run are pivotal trials that require global approach​,” Reznick said. “Our prior acquisition of a CRO in Ukraine has worked our very well. We are confident that the addition of ABR will have even greater positive impact​.” 

Related news

Related products

show more

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Formedix | 09-Jun-2021 | Technical / White Paper

This article explains the different types of clinical trial software available, and how it can be used to optimize the end to end clinical trials design...

Adapting supply chains to new ways of working

Adapting supply chains to new ways of working

World Courier | 01-Jun-2021 | Technical / White Paper

COVID-19 has changed the way we operate. We have adapted our supply chain solutions to meet our clients’ requirements while following World Courier standard...

What are the building blocks of DCTs?

What are the building blocks of DCTs?

Medable | 26-Apr-2021 | Technical / White Paper

How to create a seamless experience across eConsent, eCOA and more.

Over the past year, tremendous progress was made toward digitizing and...

How a clinical metadata repository helps with data

How a clinical metadata repository helps with data

Formedix | 22-Mar-2021 | Technical / White Paper

This article covers the various ways a clinical metadata repository helps with data quality, and in turn, with data quality in the clinical trials process....

Related suppliers

Follow us

Products

View more

Webinars